Literature DB >> 16966927

Cardiovascular disease risk reduction in older adults.

Linda Klieman1, Shauna Hyde, Kathy Berra.   

Abstract

Preventing cardiovascular events in older persons presents unique challenges to clinicians. Cardiovascular disease accounts for a large amount of disability and mortality in older persons. Older persons are often faced with unique and multiple challenges to health, including cognitive decline, social isolation, financial constraints, and physical disabilities. As more and more older persons are enrolled in studies that aim to better understand coronary heart disease and its prevention, new information is becoming available that allow clinicians to improve outcomes in the older adult. The most recent updates in the area of medical management, as well as updates of recommendations for lifestyle changes, including physical activity and dietary recommendations for older persons at risk, are presented in this article.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16966927     DOI: 10.1097/00005082-200609001-00007

Source DB:  PubMed          Journal:  J Cardiovasc Nurs        ISSN: 0889-4655            Impact factor:   2.083


  3 in total

1.  Ageing of Jamaica's Population -- What Are the Implications for Healthcare?

Authors:  D Eldemire-Shearer; K Mitchell-Fearon; H Laws; N Waldron; K James; D L Holder-Nevins
Journal:  West Indian Med J       Date:  2014-04-08       Impact factor: 0.171

2.  Hypertension and Diabetes Prevalence in Older Persons in Jamaica, 2012.

Authors:  K Mitchell-Fearon; N Waldron; K James; H Laws; D Holder-Nevins; D Eldemire-Shearer
Journal:  West Indian Med J       Date:  2014-08-14       Impact factor: 0.171

3.  Applying the ecological model of behavior change to a physical activity trial in retirement communities: description of the study protocol.

Authors:  Jacqueline Kerr; Dori E Rosenberg; Andrea Nathan; Rachel A Millstein; Jordan A Carlson; Katie Crist; Kari Wasilenko; Khalisa Bolling; Cynthia M Castro; David M Buchner; Simon J Marshall
Journal:  Contemp Clin Trials       Date:  2012-08-17       Impact factor: 2.226

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.